author-photo

Timothy R. Rebbeck

University of Pennsylvania
Harvard University

538

Papers

32972

Citations

Citation Trend

Filter By

Papers (538) Sort By

Journal Conference Others

Abstract 780: Racial disparities in death from cardiovascular disease for patients with prostate cancer: A population-based study

2021 Epidemiology
Show All
- Source
- Cite
- Save
Citations (0)
Prostate tumors of native men from West Africa show biologically distinct pathways—A comparative genomic study

2021 The Prostate
Show All
- Source
- Cite
- Save
Citations (1)
MP32-10 RACIAL DIFFERENCES IN THE TREATMENT AND OUTCOMES FOR PROSTATE CANCER IN MASSACHUSETTS

2021 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (0)
Clinical and sociodemographic factors associated with late stage cervical cancer diagnosis in Botswana.

2021 BMC Women's Health
Show All
- Source
- Cite
- Save
Citations (0)
Racial differences in the treatment and outcomes for prostate cancer in Massachusetts

2021 Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 785: Is genetic ancestry associated with mortality risk after accounting for neighborhood socioeconomic status? A study of African American men

2021 Epidemiology
Show All
- Source
- Cite
- Save
Citations (0)
The rising burden of cancer in low- and middle-human development index countries.

2021 Cancer
- Temidayo Fadelu
- Timothy R. Rebbeck
Show All
- Source
- Cite
- Save
Citations (1)
Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2.

2021 European urology focus
Show All
- Source
- Cite
- Save
Citations (2)
Abstract 67: Quantifying Transportation Barriers in Rwandan Patients Seeking Treatment for Breast Cancer

2021 Cancer Epidemiology and Prevention Biomarkers
Show All
- Source
- Cite
- Save
Citations (0)
Corrigendum to "Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations" [Gynecologic Oncology 156 (2020) 363-376].

2021 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (0)